Mid-, small-caps dent diversified mutual funds in Feb

NEW DELHI Thu Mar 3, 2011 4:02pm IST

File photo of a broker while trading at a stock brokerage firm in Mumbai November 11, 2008. Diversified stock funds lagged the Sensex in February, as exposure to mid- and small-cap shares and sectors like capital goods hurt net asset values. REUTERS/Arko Datta/Files

File photo of a broker while trading at a stock brokerage firm in Mumbai November 11, 2008. Diversified stock funds lagged the Sensex in February, as exposure to mid- and small-cap shares and sectors like capital goods hurt net asset values.

Credit: Reuters/Arko Datta/Files

Related Topics

NEW DELHI (Reuters) - Diversified stock funds lagged the benchmark Sensex in February, as exposure to mid- and small-cap shares and sectors like capital goods hurt net asset values.

Diversified funds fell 4.66 percent on an average during the month, compared with a 2.75 percent fall in the Sensex, data from global fund tracker Lipper, a Thomson Reuters company, showed.

"There is no predictability at all, there are no sectoral moves... sometimes it (market) is getting impacted by global cues," said T P Raman, Managing Director at Sundaram Mutual Fund.

Equity diversified funds with significant exposure to mid- and small-cap firms bore the brunt as the BSE Mid-cap index declined 7.2 percent and the small-cap index dropped 7.8 percent in February.

Though money managers have reduced exposure to such stocks in recent months, these companies still accounted for more than 30 percent of assets as of January-end, Morningstar India data showed.

Exposure to capital goods -- a favourite with fund managers -- which accounted for nearly a quarter of assets, also affected net asset values as the sectoral index fell 8.3 percent during February.

"Funds with higher exposure to realty, healthcare, capital goods and auto sectors took a harder knock on their chin during the month," said Dhruva Raj Chatterji, senior research analyst at Morningstar India.

Among sectoral funds, schemes which bet on pharma stocks lost 6.9 percent in February, as the healthcare index posted a drop of 8.32 percent.

Diversified equity funds had 6.6 percent of their assets allocated to cash at end-January, their highest level since February 2010, data showed.

Fund managers have increased their allocation to cash, as a spate of corruption scandals, high inflation and rising crude oil prices dented sentiment and led to a fall in key indices.

"It appears that some of the funds which took larger cash calls during the correction may also have buffered themselves a bit amidst the turmoil," Chatterji said.

BOND, GOLD FUNDS

Indian fixed income funds investing in government debt saw net values rise 0.67 percent in February, as the yield on the actively traded benchmark bond fell eight basis points in the month.

India's gold exchange-traded funds (ETFs) gained 3.8 percent in February as the price of the yellow metal jumped on the back of political turmoil in Libya.

On the continuous charts in India, gold futures ended February at 20,923 rupees per 10 grams, up 5 percent for the month.

(Additional reporting by Neha D' Silva, Editing by Sunil Nair)

FILED UNDER:

"India's Daughter"

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage